- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04726761
Frequent Cuff Inflations May Disrupt the Accuracy of 24-hour Ambulatory Blood Pressure Monitoring
24-hour ambulatory blood pressure monitoring (ABPM) is superior to office blood pressure (BP) for assessing cardiovascular risk. On the other hand, repeated cuff inflations during ABPM can cause discomfort and reduced quality of sleep. A high frequency of measurement during ABPM might result in erroneously high BP measurement, incorrect hypertension diagnoses, unnecessary treatment or just overtreatment with antihypertensive medication and potentially serious side effects.
The purpose of this study is to investigate whether the frequency of measurements during ABPM impacts the measured BP during ABPM.
Patients will be recruited from the Clinic of Hypertension at Aarhus University Hospital, Denmark. The study will be conducted as a randomized controlled crossover study. Participants will undergo two 24-hour ABPMs: One with a low frequency of measurement, 1-time per hour during the day and 1-time per hour during the night, and one with a high frequency, 3-times/hour during the day, and 2-times/hour at night. The primary endpoint will be the difference in 24-hour mean systolic BP between the high- and low frequency measurement ABPM.
Study Overview
Status
Conditions
Detailed Description
Aim:
The purpose of this study is to evaluate if 24-hour ABPM with frequent BP measurements (intervals of 20 minutes during daytime and 30 minutes during nighttime) result in erroneously elevated BP in hypertensive patients compared with non-frequent BP readings (measurement intervals of 60 minutes both day and night).
Population:
The study population will comprise all patients referred to and attending the Clinic of Hypertension, AUH, who are scheduled to undergo ABPM. At referral to the Clinic of Hypertension, AUH, patients will be contacted with an electronic or analog letter, informing them about the study and inviting them to participate. Patients who already are being treated at the Clinic of Hypertension, will be invited at an appointment in the clinic. Patients will be excluded from the study if they have atrial fibrillation, nighttime work, insomnia or sleeping disorders, and are not physically able to undergo an ABPM (e.g. too big arm circumference to fit the cuff).
Methods:
This will be a randomized controlled crossover study (figure 2). At arrival patients will be fitted with the device, a SPACELABS 90217 by a nurse. The nurse will conduct an office blood pressure measurement, in accordance with ESH guidelines to be sure the device is working, and for later comparison. Patients will have their first ABPM conducted with either frequent or non-frequent ABPM measurement protocol as described above, randomized 1:1. Patients will be instructed to remove their device after 24 hours of measurement and have an appointment to return the device between 2-7 days. At least two days between measurements ensure a sufficient washout period. The maximum of 7 days before second measurement makes sure the patient's appointment with a doctor at the clinic will not be delayed. When returning the device, patients will have the same device mounted again, measuring with the frequency not assigned at the initial randomization. Participants will be instructed to repeat the same procedures regarding the device and to, as far as possible, conduct the same daily activities on the second day of measurement as during the first day of measurement. Patients will not have any alterations in blood pressure medication between the two measuring days. After each ABPM, patients will answer a routine questionnaire from the clinic about sleep, discomfort, pain, and the degree to which the device caused interference with daily activities and/or disturbance of sleep. Since the questionnaire is standard procedure at the clinic, we will be able to compare characteristics between the group who are not interested in joining the study and patients do participate. In this way the investigators can ensure no unknown selection bias occurs. Both ABPM will be used by the clinician at the appointment in the clinic.
Sample size:
In a pilot study conducted at the Clinic of Hypertension, AUH, the investigators found a mean difference of 7 mmHg (Standard deviation = 13,76) between a 20-minute interval and a 1-hour interval between measurements, respectively. Using a sample size calculation, for crossover design with quantitative measurement, a two-sided significance level of 0.025 and a power of 0.9, and a minimal clinical difference of 10mmHg, we calculate a minimum sample size of 38 patients. It is estimated only 25% of patients with this difference will be in intermediate hypertension group as studied in the previous pilot study, which is why 152 patients wil be included.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Aarhus, Denmark, 8200
- Hypertension Clinic, Aarhus University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients either has to be referred from primary care to the Clinic of Hypertension at Aarhus University hospital, or already being treated at the clinic. Both groups has to be scheduled for a 24-hour ambulatory blood pressure monitoring.
Exclusion Criteria:
- Below 18 years of age
- Have atrial fibrillation
- Have routine nightshift work
- Is pregnant
- Is physically inable to have the cuff applied correctly (too large arm circumference)
- Known insomnia or other sleeping disorders
- Change in blood pressure medication within 14 days before inclusion
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Frequent/Non-frequent
Patients randomized to this order will first have an ABPM conducted with the frequent measuring intervals (3 times an hour during day and 2 times an hour at night) and then a few days later have another ABPM conducted with the non-frequent measuring interval (1 time an hour during all 24 hours)
|
Patient will have a Spacelabs 90217 attached.
This device can automatically measure the blood pressure over 24 hours.
Patients will have their blood pressure measured first with a frequent interval, and then a non-frequent interval.
|
Non-frequent/frequent
Patients randomized to this order will first have an ABPM conducted with the non-frequent measuring interval (1 time an hour during all 24 hours) and then a few days later have another ABPM conducted with the frequent measuring intervals (3 times an hour during day and 2 times an hour at night)
|
Patient will have a Spacelabs 90217 attached.
This device can automatically measure the blood pressure over 24 hours.
Patients will have their blood pressure measured first with a non-frequent interval, and then a frequent interval.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The difference in mean systolic blood pressure (SBP) between 24-hour ABPM with frequent and non-frequent measurement intervals
Time Frame: One week
|
The systolic blood pressure is one of the most important predictors of a patient's risk of cardiovascular disease that can be measured with ABPM.
|
One week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The difference in mean diastolic blood pressure (DBP) between 24-hour ABPM with frequent and non-frequent measurement intervals.
Time Frame: One week
|
Diastolic blood pressure is an important predictor of a patient´s risk of cardiovascular disease that can be measured with ABPM.
|
One week
|
The self-reported pain/discomfort, interference in daily life, and disturbance of sleep during frequent and non-frequent measurement ABPM
Time Frame: One week
|
Self-reported data from a questionnaire, to see if there is a correlation between these factors and a possible difference in measured blood pressure.
|
One week
|
The difference in average real variability (ARV), dipping status and morning surge during frequent and non-frequent measurement ABPM.
Time Frame: One week
|
These are less common but also important factors in regards of a patients blood pressure profile, used to asses a patient's risk of cardiovascular disease.
|
One week
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Niels Henrik Buus, Klinisk Institut, Aarhus Universitets Hospital
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1337
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
Clinical Trials on Ambulatory Blood Pressure Monitoring, frequent/non-frequent
-
Boehringer IngelheimCompleted
-
Shalvata Mental Health CenterUnknownPersonality Disorders | Psychotic Disorders | Anxiety Disorders | Affective DisordersIsrael
-
GWT-TUD GmbHNovartisCompletedDiabetic Macular EdemaGermany
-
University of MichiganCompletedHypertensionUnited States
-
General Administration of Military Health, TunisiaRecruiting
-
Yokohama City University Medical CenterCompletedDiabetes Mellitus | Renal Failure | Essential Hypertension | Chronic NephropathyJapan
-
Italian Institute of TelemedicineItalian Society of Hypertension; Italian Society of General Practitioners; Biotechmed...Recruiting
-
Italian Institute of TelemedicineBPLabCompletedHypertensionRussian Federation, Argentina, Armenia, Australia, Italy, Kazakhstan, Mexico, Portugal, Romania, Ukraine
-
University of VigoUniversity of California, Los Angeles; National Institute on Minority Health... and other collaboratorsRecruiting
-
Seoul National University HospitalKangbuk Samsung Hospital; Severance Hospital; Eulji General HospitalUnknownHypertension | Chronic Kidney Diseases | Renal Insufficiency, Chronic | AlbuminuriaKorea, Republic of